These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 34281253)
1. Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives. Kim IH; Lee HJ Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281253 [TBL] [Abstract][Full Text] [Related]
2. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder. Rouanne M; Bajorin DF; Hannan R; Galsky MD; Williams SB; Necchi A; Sharma P; Powles T Eur Urol Oncol; 2020 Dec; 3(6):728-738. PubMed ID: 33177001 [TBL] [Abstract][Full Text] [Related]
3. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer. Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530 [TBL] [Abstract][Full Text] [Related]
4. Perioperative systemic therapy in muscle invasive bladder cancer: Current standard method, biomarkers and emerging strategies. Kim KH; Lee HW; Ha HK; Seo HK Investig Clin Urol; 2023 May; 64(3):202-218. PubMed ID: 37341001 [TBL] [Abstract][Full Text] [Related]
6. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis. Boutaleb I; Mjaess G; Roumeguère T Fr J Urol; 2024 Sep; 34(9):102704. PubMed ID: 39059767 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we? Osanto S; Álvarez Gómez de Segura C Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716 [TBL] [Abstract][Full Text] [Related]
8. [Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer]. Schmid SC; Koll FJ; Beckert F; Seitz AK Urologe A; 2020 Jul; 59(7):790-796. PubMed ID: 32472221 [TBL] [Abstract][Full Text] [Related]
9. Current Perioperative Therapy for Muscle Invasive Bladder Cancer. Ma J; Black PC Hematol Oncol Clin North Am; 2021 Jun; 35(3):495-511. PubMed ID: 33958147 [TBL] [Abstract][Full Text] [Related]
10. [Classical chemotherapy, immunotherapy, or adjuvant radiotherapy-how to improve the oncologic outcome of radical cystectomy?]. Paffenholz P; Zschäbitz S Urologie; 2024 Oct; 63(10):994-1001. PubMed ID: 39285097 [TBL] [Abstract][Full Text] [Related]
18. Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions. Cockrell DC; Rose TL Curr Oncol Rep; 2023 May; 25(5):511-520. PubMed ID: 36897554 [TBL] [Abstract][Full Text] [Related]
19. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341 [TBL] [Abstract][Full Text] [Related]
20. Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma. Nadal R; Apolo AB Curr Treat Options Oncol; 2018 May; 19(7):36. PubMed ID: 29808294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]